Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials

Core Insights - Vor Bio presented research highlighting the need to enhance patient experience and address barriers in cell and gene therapy (CGT) trial enrollment [1][2] - The study identified significant challenges in educating patients about CGT trials and emphasized the interest of physicians in these innovative therapies [2][9] Group 1: Research Findings - The research revealed opportunities for institutions and trial sponsors to improve patient experience and streamline enrollment processes in CGT trials [3] - Key barriers include the complexity of CGT, logistical challenges, and resource constraints at trial sites, which delay patient enrollment [8] - The study involved surveys and interviews with 30 healthcare professionals, including physicians and study coordinators, to assess the challenges faced in the patient consent process [2][3] Group 2: Recommendations and Future Directions - Clinical trial sponsors are encouraged to provide comprehensive educational content to help patients understand CGT options better [3] - Establishing specialized CGT research teams in hospitals could enhance their capacity to offer more trials and treat additional patients [3] - Vor Bio plans to continue research to uncover further insights that could lead to improvements in patient experience and CGT trial enrollment [4]